BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 34546371)

  • 1. Variation in Diagnosis, Treatment, and Outcome of Esophageal Cancer in a Regionalized Care System in Ontario, Canada.
    Habbous S; Yermakhanova O; Forster K; Holloway CMB; Darling G
    JAMA Netw Open; 2021 Sep; 4(9):e2126090. PubMed ID: 34546371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readmission rates following esophageal cancer resection are similar at regionalized and non-regionalized centers: A population-based cohort study.
    Gupta V; Bubis L; Kidane B; Mahar AL; Ringash J; Sutradhar R; Darling GE; Coburn NG
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):934-942.e2. PubMed ID: 31176552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
    Franko J; Voynov G; Goldman CD
    Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy for esophageal cancer: is it worthwhile?
    Tamim WZ; Davidson RS; Quinlan RM; O'Shea MA; Orr RK; Swanson RS
    Arch Surg; 1998 Jul; 133(7):722-6. PubMed ID: 9687999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between hospital case-volume and postoperative outcomes after esophageal cancer surgery: A population-based retrospective cohort study.
    Kim BR; Jang EJ; Jo J; Lee H; Jang DY; Ryu HG
    Thorac Cancer; 2021 Sep; 12(18):2487-2493. PubMed ID: 34355527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
    Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
    JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
    Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
    Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Surgical Approach on Long-term Survival in Esophageal Adenocarcinoma Patients With or Without Neoadjuvant Chemoradiotherapy.
    Noordman BJ; van Klaveren D; van Berge Henegouwen MI; Wijnhoven BPL; Gisbertz SS; Lagarde SM; van der Gaast A; Hulshof MCCM; Biermann K; Steyerberg EW; van Lanschot JJB;
    Ann Surg; 2018 May; 267(5):892-897. PubMed ID: 28350565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
    Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Treatment of T1N0 Esophageal Cancer.
    Semenkovich TR; Hudson JL; Subramanian M; Mullady DK; Meyers BF; Puri V; Kozower BD
    Ann Surg; 2019 Sep; 270(3):434-443. PubMed ID: 31274653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched Analysis.
    Mokdad AA; Yopp AC; Polanco PM; Mansour JC; Reznik SI; Heitjan DF; Choti MA; Minter RR; Wang SC; Porembka MR
    JAMA Oncol; 2018 Jan; 4(1):31-38. PubMed ID: 28975352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
    Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
    J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of locoregional stage esophageal cancer: a single center experience.
    Javle MM; Nwogu CE; Donohue KA; Iyer RV; Brady WE; Khemka SV; Smith JL; Demmy TL; Yang GY; Nava HR
    Dis Esophagus; 2006; 19(2):78-83. PubMed ID: 16643174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of clinical T2N0M0 esophageal cancer.
    Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
    Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esophageal Cancer Surgery: Spontaneous Centralization in the US Contributed to Reduce Mortality Without Causing Health Disparities.
    Schlottmann F; Strassle PD; Charles AG; Patti MG
    Ann Surg Oncol; 2018 Jun; 25(6):1580-1587. PubMed ID: 29349529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Repeat 18F-Fluorodeoxyglucose Positron Emission Tomography Examination in Predicting Pathologic Response Following Neoadjuvant Chemoradiotherapy for Esophageal Adenocarcinoma.
    Kukar M; Alnaji RM; Jabi F; Platz TA; Attwood K; Nava H; Ben-David K; Mattson D; Salerno K; Malhotra U; Kanehira K; Gannon J; Hochwald SN
    JAMA Surg; 2015 Jun; 150(6):555-62. PubMed ID: 25902198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
    Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
    Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma.
    Bates BA; Detterbeck FC; Bernard SA; Qaqish BF; Tepper JE
    J Clin Oncol; 1996 Jan; 14(1):156-63. PubMed ID: 8558191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment utilization and outcomes in elderly patients with locally advanced esophageal carcinoma: a review of the National Cancer Database.
    Vlacich G; Samson PP; Perkins SM; Roach MC; Parikh PJ; Bradley JD; Lockhart AC; Puri V; Meyers BF; Kozower B; Robinson CG
    Cancer Med; 2017 Dec; 6(12):2886-2896. PubMed ID: 29139215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.